Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondansetron injections
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The trial also demonstrated significant improvements across multiple secondary endpoints
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
Subscribe To Our Newsletter & Stay Updated
